A Study of 28431754 (Canagliflozin) on Gastrointestinal Glucose Absorption and Metabolism in Healthy Volunteers

NCT01173549 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Canagliflozin/Placebo Placebo/Canagliflozin
OTHER: no intervention

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.